Metaforest Algorithm Insights: Predictors of Nocebo Response in ADHD
Porta, Mieria (Universitat de Girona)
Barcheni, Maghie (Universitat Autònoma de Barcelona)
Ramírez-Saco, David (Hospital Universitari Vall d'Hebron)
Cunill, Ruth (Parc Sanitari Sant Joan de Déu)
Farré Albaladejo, Magí (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Saez, Marc (Universitat de Girona)
López, Beatriz (Universitat de Girona)
Castells Cervelló, Xavier (Universitat de Girona)

Data:	2025
Resum:	BACKGROUND: Predicting the nocebo response in randomized controlled trials (RCTs) is crucial as it can help minimize its influence and improve the evaluation of the side effects of interventions for ADHD. The aim of this study is to determine the effect of covariates related to study design, intervention, and patients' characteristics on the nocebo response in patients with Attention Deficit Hyperactivity Disorder (ADHD) using Metaforest, and, ultimately, to investigate Metaforest's performance in predicting nocebo response in ADHD RCTs. METHODS: This study is a secondary analysis of a previously published systematic review [1]. Nocebo response was defined as the proportion of patients experiencing at least one AE while receiving a placebo. We used Metaforest for investigating patient-, intervention, and study design-related nocebo response moderators in ADHD RCTs. RESULTS: One hundred and five studies were included. Overall, 55. 4% of patients experienced at least one AE while receiving placebo. However, between-study variability on nocebo response was very high, with nocebo response ranging from 4. 2% to 90. 2%, leading to high statistical heterogeneity (I2 = 88. 3%). Older patients showed a higher nocebo response. The moderating effects of the year of publication, treatment length and gender were also significant. The predictive performance of the model was low-moderate (R2 test = 0, 1922; MSE = 0, 0408). CONCLUSION: Age was the most important nocebo response modifier, followed by year of publication, treatment length and gender. Metaforest lacked the capability to predict nocebo responses in future studies.
Drets:	Aquest material està protegit per drets d'autor i/o drets afins. Podeu utilitzar aquest material en funció del que permet la legislació de drets d'autor i drets afins d'aplicació al vostre cas. Per a d'altres usos heu d'obtenir permís del(s) titular(s) de drets.
Llengua:	Anglès
Document:	Article de revisió ; recerca ; Versió acceptada per publicar
Matèria:	Metaforest ; Nocebo response ; ADHD ; Placebo ; Heterogeneity
Publicat a:	Current Psychopharmacology, Vol. 12 num. 1 (2024) , ISSN 2211-5579

DOI: 10.2174/0122115560338571241220113154

Disponible a partir de: 2026-11-30

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències de la salut i biociències > Institut d'Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP)
Articles > Articles de recerca
Articles > Articles publicats